MBOT
vs
S&P 500
MBOT
S&P 500
Over the past 12 months, MBOT has significantly outperformed S&P 500, delivering a return of +114% compared to the S&P 500's +14% growth.
Stocks Performance
MBOT vs S&P 500
Performance Gap
MBOT vs S&P 500
Performance By Year
MBOT vs S&P 500
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Microbot Medical Inc
Glance View
Microbot Medical, Inc. is a pre-clinical medical device company, which engages in the research, design, development, and commercialization of micro-robotics assisted medical technologies. The company is headquartered in Hingham, Massachusetts and currently employs 17 full-time employees. The company specializes in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. Its technological platforms include ViRob, TipCAT, LIBERTY and certain CardioSert assets. The ViRob is an autonomous crawling micro-robot, which can be controlled remotely or within the body. The TipCAT is a disposable self-propelled locomotive device that is specially designed to advance tubular anatomy. LIBERTY is designed to maneuver guidewires and over-the-wire devices, such as microcatheters within the body's vasculature. The company is developing Self-Cleaning Shunt (SCSTM), for the treatment of hydrocephalus and Normal Pressure Hydrocephalus (NPH) using ViRob platform. The company is developing the fully disposable robot for various endovascular interventional procedures using LIBERTY and CardioSert platforms. The company is also focused on the development of a multi generation pipeline portfolio.
